Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
23
VTGN Quote, Financials, Valuation and Earnings
Last price:
$0.72
Seasonality move
:
20.93%
Day range:
$0.70 - $0.74
52-week range:
$0.68 - $5.14
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
25.55x
P/B ratio:
0.43x
Volume:
1.8M
Avg. volume:
4.2M
1-year change:
-71.45%
Market cap:
$28.7M
Revenue:
$486K
EPS (TTM):
-$1.90
Earnings Data
Next earnings date for VTGN
Feb 12
2026
Most recent earnings per share
-$0.54
Missed by $0.10
(Nov 13/2025)
Consensus Estimate
-$0.44
(Nov 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VTGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $139.5K | -- | -- | -$0.49 | -- |
| 11/13/2025 | Q3 | $145.8K | $258K | -$0.54 | -$0.44 | -$0.10 |
| 08/07/2025 | Q2 | $215.7K | $244K | -$0.47 | -$0.44 | -$0.03 |
| 06/17/2025 | Q1 | $209.3K | -- | -- | -$0.49 | -- |
| 02/13/2025 | Q4 | $179.3K | $234K | -$0.46 | -$0.52 | $0.06 |
| 11/07/2024 | Q3 | $33.3K | $183K | -$0.42 | -$0.38 | -$0.04 |
| 08/13/2024 | Q2 | $298.5K | $84K | -$0.35 | -$0.41 | $0.06 |
| 06/11/2024 | Q1 | $202.8K | $197K | -$0.35 | -$0.33 | -$0.02 |
| 02/13/2024 | Q4 | $544.5K | $411.4K | -$0.22 | -$0.27 | $0.05 |
| 11/09/2023 | Q3 | -- | -- | -$0.66 | -$0.68 | $0.02 |
| 08/10/2023 | Q2 | -- | -- | -$0.94 | -$0.86 | -$0.08 |
| 06/23/2023 | Q1 | -- | -- | -$1.69 | -$1.50 | -$0.19 |
| 02/07/2023 | Q4 | -- | -- | -$1.42 | -$1.80 | $0.38 |
| 11/10/2022 | Q3 | -- | -- | -$2.54 | -$0.60 | -$1.94 |
| 08/11/2022 | Q2 | -- | -- | -$2.87 | -$2.25 | -$0.62 |
| 06/23/2022 | Q1 | -- | -- | -$2.58 | -- | -- |
| 02/10/2022 | Q4 | -- | -- | -$1.50 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$2.10 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$1.20 | -- | -- |
| 06/29/2021 | Q1 | -- | -- | -$4.91 | -- | -- |
| 02/11/2021 | Q4 | -- | -- | -$2.10 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$1.50 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$2.10 | -- | -- |
| 06/29/2020 | Q1 | -- | -- | -$2.10 | -- | -- |
| 02/13/2020 | Q4 | -- | -- | -$4.50 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$3.90 | -- | -- |
| 08/13/2019 | Q2 | -- | -- | -$4.50 | -- | -- |
| 06/25/2019 | Q1 | -- | -- | -$4.50 | -- | -- |
| 02/12/2019 | Q4 | -- | -- | -$7.20 | -- | -- |
| 10/29/2018 | Q3 | -- | -- | -$9.00 | -- | -- |
| 08/14/2018 | Q2 | -- | -- | -$6.00 | -- | -- |
| 06/26/2018 | Q1 | -- | -- | -$5.68 | -- | -- |
| 02/12/2018 | Q4 | -- | -- | -$7.50 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$15.90 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$8.40 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$9.30 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$10.20 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$12.60 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$15.30 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$108.90 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$58.50 | -- | -- |
Vistagen Therapeutics, Inc. Earnings Questions
-
How Much did Vistagen Therapeutics, Inc. Generate in Revenue Last Quarter?
Vistagen Therapeutics, Inc. reported $258K worth of top line sales in its most recent quarter.
-
Did Vistagen Therapeutics, Inc. Beat Earnings Last Quarter?
Vistagen Therapeutics, Inc. announced earnings per share of -$0.54 which represents a miss of analyst forecast a -$0.44 per share.
-
Is Vistagen Therapeutics, Inc. Profitable?
Vistagen Therapeutics, Inc. reported $73K that represents $0.00 per share over the last quarter.
-
What is the Analyst Consensus for Vistagen Therapeutics, Inc. EPS Next Year?
Vistagen Therapeutics, Inc.'s earnings are forecast to decrease from -$1.67 per share to -$1.74 per share next year representing a decrease of -9.75%.
-
When is Vistagen Therapeutics, Inc.'s Earnings Date?
Vistagen Therapeutics, Inc.'s next earnings date is February 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
